Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID‐19: A Case Series

Study (n=11) reports seven patients who were initiated on anakinra treatment ≤36 hours after onset of acute hypoxic respiratory failure did not require mechanical ventilation, and all were discharged home.

Source:

Arthritis & Rheumatology